Dassonneville L, Lansiaux A, Wattelet A, Wattez N, Mahieu C, Van Miert S, Pieters L, Bailly C
INSERM U-524 and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Place de Verdun, 59045, Lille, France.
Eur J Pharmacol. 2000 Dec 1;409(1):9-18. doi: 10.1016/s0014-2999(00)00805-0.
Cryptolepine and neocryptolepine are two indoloquinoline derivatives isolated from the roots of the african plant Cryptolepis sanguinolenta. These two alkaloids, which only differ by the respective orientation of their indole and quinoline rings, display potent cytotoxic activities against tumour cells and present antibacterial and antiparasitic properties. Our previous molecular studies indicated that these two natural products intercalate into DNA and interfere with the catalytic activity of human topoisomerase II. Here we have extended the study of their mechanism of action at the cellular level. Murine and human leukemia cells were used to evaluate the cytotoxicity of the drugs and their effects on the cell cycle were measured by flow cytometry. Cryptolepine, and to a lesser extent neocryptolepine, provoke a massive accumulation of P388 murine leukemia cells in the G2/M phase. With HL-60 human leukemia cells, the treatment with cryptolepine leads to the appearance of a hypo-diploid DNA content peak (sub-G1) characteristic of the apoptotic cell population. With both P388 and HL-60 cells, cryptolepine proved about four times more toxic than its isomer. But the use of the HL-60/MX2 cell line resistant to the anticancer drug mitoxantrone suggests that topoisomerase II may not represent the essential cellular target for the alkaloids, which are both only two times less toxic to the resistant HL-60/MX2 cells compared to the parental cells. The capacity of the drugs to induce apoptosis of HL-60 human leukemia cells was examined by complementary biochemical techniques. Western blotting analysis revealed that cryptolepine, but not neocryptolepine, induces cleavage of poly(ADP-ribose) polymerase but both alkaloids induce the release of cytochrome c from the mitochondria. The cleavage of poly(ADP-ribose) polymerase observed with cryptolepine correlates with the appearance of a marked sub-G1 peak in the cell cycle experiments. The proteolytic activity of Asp-Glu-Val-Asp- or Ile-Glu-Thr-Asp-caspases was found to be enhanced much more strongly with cryptolepine than with its isomer, as expected from their different cytotoxic potential. Despite the activation of the caspase cascade, we did not detect internucleosomal cleavage of DNA in the HL-60 cells treated with the alkaloids. Altogether, the results shed light on the mechanism of action of these two plant alkaloids.
隐丹参酮和新隐丹参酮是从非洲植物红根草的根中分离出的两种吲哚喹啉衍生物。这两种生物碱仅在吲哚环和喹啉环的各自取向上有所不同,它们对肿瘤细胞具有强大的细胞毒活性,并具有抗菌和抗寄生虫特性。我们之前的分子研究表明,这两种天然产物可嵌入DNA并干扰人类拓扑异构酶II的催化活性。在此,我们在细胞水平上扩展了对其作用机制的研究。使用小鼠和人类白血病细胞评估药物的细胞毒性,并通过流式细胞术测量它们对细胞周期的影响。隐丹参酮,以及程度稍轻的新隐丹参酮,会使P388小鼠白血病细胞在G2/M期大量积累。对于HL-60人类白血病细胞,用隐丹参酮处理会导致出现凋亡细胞群体特有的亚二倍体DNA含量峰(亚G1期)。对于P388和HL-60细胞,隐丹参酮的毒性均约为其异构体的四倍。但是,使用对抗癌药物米托蒽醌耐药的HL-60/MX2细胞系表明,拓扑异构酶II可能不是这些生物碱的主要细胞靶点,与亲代细胞相比,这两种生物碱对耐药的HL-60/MX2细胞的毒性仅低两倍。通过补充生化技术检测了药物诱导HL-60人类白血病细胞凋亡的能力。蛋白质印迹分析显示,隐丹参酮而非新隐丹参酮可诱导聚(ADP-核糖)聚合酶的裂解,但两种生物碱均可诱导线粒体释放细胞色素c。在细胞周期实验中,用隐丹参酮观察到的聚(ADP-核糖)聚合酶的裂解与明显的亚G1峰的出现相关。正如预期的那样,由于它们不同的细胞毒性潜力,天冬氨酸-谷氨酸-缬氨酸-天冬氨酸或异亮氨酸-谷氨酸-苏氨酸-天冬氨酸半胱天冬酶的蛋白水解活性在隐丹参酮作用下比在其异构体作用下增强得更为强烈。尽管半胱天冬酶级联反应被激活,但在用生物碱处理的HL-60细胞中未检测到DNA的核小体间裂解。总之,这些结果揭示了这两种植物生物碱的作用机制。